Full Transcript Introduction to Peptides and Perimenopause 0:00 Welcome back everyone. 0:01 My next guest is someone I am truly excited 0:03 to have on this virtual stage, because we're about to dive into a conversation 0:08 that is very popular, and I don't think we can talk about it enough. 0:13 It's the intersection of peptides bioregulators and one of the most 0:16 underserved transition in women's health perimenopause. 0:19 I think we might not talk too much about Bioregulators here, 0:22 but we're going to focus on the peptides, which is big. 0:25 Doctor Patrick Taylor is a medical doctor and the founder of Live Vital, 0:29 where he works at the cutting edge of regenerative and longevity medicine. 0:32 His approach is integrative evidence formed and deeply patient centered. 0:36 He's built a reputation for helping women navigate the hormonal and cellular 0:40 changes of midlife with precision tools that go well beyond conventional care. 0:45 Today, we're going to talk about how peptides can support women 0:48 through the perimenopausal transition from hormonal fluctuations 0:52 and brain fog to energy body composition, sleep and beyond. 0:56 This is the kind of nuanced, 0:57 clinically grounded conversation but I know this community has been hungry for. 1:02 So please welcome Doctor Patrick Taylor. 1:04 Thanks for taking the time. 1:06 Yeah, thanks so much, Natalie. 1:07 Happy to be here and excited to talk about it. 1:10 Yeah. 1:10 Well, you know, 1:11 I think I'm 1:12 going to ask the first question that is the, you know, might seem obvious. 1:15 Talk to me about a relatively young doctor male 1:20 who's decided that perimenopause is going to be treating, dealing with, 1:24 helping women deal with period. 1:26 Is going to be his superpower. 1:27 What made you pick this direction? 1:29 Yeah. Yeah. 1:30 I mean, I think my entire medical career led me to this. 1:34 When I look at my personal history, I struggled with Cushing's 1:38 syndrome after having cancer as a kid and taking prednisone for a year. 1:43 I then had 100 pound weight loss while I was in medical school 1:46 and struggled through that metabolic shift and became deeply interested 1:51 in how hormones affect metabolism and how that. 1:56 And then as I went through my medical training as a family medicine board 2:00 certified doctor, I realized that there was this huge gap
Why Perimenopause Became the Focus 2:04 in healthcare where we have an aging population of women. 2:08 We have more women from the ages of 35 to 65 than we do of any other age. 2:14 And we have OB GYNs, who for the most part, you know, 2:18 know the medicine, but maybe don't have the time 2:20 or want to do surgery, or don't want to focus on it, 2:23 or have been telling people it's just a part of the process. 2:26 And then there's a family physicians who are too busy 2:30 and don't have enough time to discuss treatment options 2:33 and really just don't understand all of the different treatment options available. 2:36 And so I saw this huge gap and I said, I can do this. 2:39 And I became a meta pause certified practitioner and have been able 2:42 to see how much it truly benefits people's lives. 2:46 And as like a former college athlete and somebody who like, likes results, 2:50 I love that this is a population of people that I can actually help 2:54 see results instead of just like chronic disease management. 2:59 Yeah, no. 3:00 And in many ways prevent chronic disease down the road, 3:03 which I think that's the thing that a lot of people miss. 3:07 So many women and women I even speak to will say, well, I don't get hot flashes. 3:12 So I'm not I don't need hormone therapy. 3:14 And I think what gets missed in the conversation for a lot of people still, 3:19 which is amazing, is that this is not just about whether you're 3:23 getting sweaty at night, like it has to do with your bones and your brain 3:26 and how you're going to age and how you're going to kind of, 3:31 you know, make it through your 70s, 80s and potentially beyond. 3:34 And that it starts now. Yeah, absolutely. 3:38 And that's just the beginning of the conversation. Right? 3:40 Is understanding that perimenopause, meaning the 7 to 14 years before you have 3:46 your last period, is actually the most important time to start therapy, 3:51 whether it's menopausal hormone therapy, which has been shown to decrease 3:54 cardiovascular risk, to decrease dementia, osteoporosis, diabetes risk, 3:59 but also to address the factors that come with paramount pause 4:03 because other than pregnancy, there's not another time in a woman's life 4:09 where she develops an underlying inherent insulin resistance. 4:14 And I studied under Ben Beekman, who's one of the top insulin 4:17 resistance and ketogenic diet researchers in the world. 4:20 And, you know, since that time, I've been all in on 4:24 insulin resistance is one of the leading causes of chronic disease. 4:27 You know, it's not everything. 4:29 But yeah, when you look 4:30 at chronic disease, heart disease, hypertension, kidney disease, diabetes, 4:35 I mean, it really comes down to insulin resistance, which is huge for women. 4:41 Well, I mean, it's huge
The Four Clinical Buckets 4:42 in any body that that develops and honestly. 4:45 But we're going to talk just about the girls today. 4:47 So before we started recording, you talk to me about your approach 4:52 to helping to figure out what's really going 4:55 to help your patient when she's sitting across the table from you. 4:59 And you talked about kind of parsing things out into four main buckets, 5:04 do you want to maybe 5:04 just talk about each of those buckets and how they show up for people? 5:08 And then what we'll do is coming out of 5:10 that will then start to talk a little bit about where the peptides fit 5:14 in, when you're dealing with each one of these buckets. 5:18 Yeah, absolutely. I'd love to talk about that. 5:20 You know, when I look at Paramount pause, not only is it 5:23 like this massive hormonal shift where you have fluctuating estrogen 5:27 and progesterone and it's unpredictable and all of those things 5:30 and the insulin resistance, but I really look at it in four main buckets. 5:34 And this has to do with both aging and the menopausal shift. 5:39 But the four main buckets I look at when deciding on peptide 5:43 therapies to utilize for patients is either insulin resistance, 5:47 inflammation, hormonal imbalances, or cellular inefficiencies. 5:51 And so when you dive into each one of those buckets, obviously 5:55 there are symptoms. 5:56 And then signs like laboratory signs and physical exam findings 6:00 and such that can go with each of those buckets. 6:04 So insulin resistance is like the low hanging fruit, right. 6:07 It's like obviously if you have difficulty losing weight, 6:12 gaining belly fat, visceral fat, increased joint pain fatigue. 6:17 And then obviously the lab findings like an increased fasting insulin 6:20 and increased fasting glucose increase cholesterol, triglyceride, HDL ratios 6:26 and even cortisol, which I'll kind of lump into the hormonal bucket. 6:29 But that insulin resistance is almost 6:32 always predictable in women in the perimeter puzzle stage. 6:36 And it's just when is it going to happen? 6:39 Yeah, it's part of the package. 6:41 Yeah, absolutely. 6:42 Like I have women who are, you know, 12% body fat and they had a huge increase 6:47 in their fasting insulin and their cholesterol, 6:49 despite no changes in their diet or exercise during perimenopause. 6:52 Right. Yeah. 6:54 So it's it's one of those true times in your life 6:57 where it's like you're not doing anything wrong 6:59 and yet you're not getting the results and you're doing everything right. 7:03 Yeah. 7:03 Tell us about fasting insulin, because that's not a number that a lot of people. 7:06 It's a number that gets missed by a lot of people. 7:09 So what's the range of fasting insulin that you like to see in your patients? 7:13 Yeah, absolutely. 7:15 You know, 7:15 I think for so many practitioners, especially in traditional Western 7:19 medicine, you know, you get a screening A1 for someone and that was normal. 7:24 You're not pre-diabetic or diabetic. 7:26 So you're good and a fasting glucose. 7:28 But when you look at insulin resistance, glucose changes 7:32 which are so tightly regulated by insulin and glucagon, 7:36 is actually one of the last things to change when you are insulin resistant. 7:40 So your insulin can be going up and up and up and up for years, 7:43 and your receptors can become less and less sensitive for years prior 7:47 to having an agency that's elevated. 7:51 Right. Right. 7:52 And so I typically try to use more optimal levels. 7:55 So anywhere anything less than five is like you are killing it with your insulin. 8:00 Like a fasting insulin less than five you are dialed anything above ten, 8:06 I'm like, okay, we're like, we're definitely an insulin resistance above 15. 8:10 You are extremely insulin resistant. 8:13 The normal level that you'll see on labs can range anywhere from 8 to 15. 8:18 But I have seen in many of my patients, when we truly start to see the effects 8:24 of true insulin sensitivity, it's less than five 8:29 on a fasting insulin, right. 8:31 And then where, you know, and again, even with HbA onesie and fasting 8:35 and glucose numbers, there's a big variant 8:38 where where are you liking to see those numbers come in. 8:42 Because, you know, you've 8:43 I mean, I think conventional medicine is anything under six is great. 8:47 And we both know that 5.8 is awfully close to the edge. 8:51 Yeah, absolutely. 8:52 You know, it's interesting I used to use a onesie 8:55 far more and say like, hey, let's target less than five. 8:59 You know, anything that starts with the four, you're doing pretty well. 9:02 Yeah. 9:03 The tricky thing again with that is I have seen people 9:07 with a fasting insulin of ten with an a onesie of 5.2 9:12 and people with a fasting insulin of ten with an agency of 4.8. 9:16 And so and again, it's because it really is 9:20 kind of a onesie is such a late stage change in insulin resistance 9:25 when you look at like what changes first and what changes last, like 9:29 when you're at the a onesie stage and you're going up, that means you're insulin 9:34 resistant enough to wear your glucose, which is the most tightly regulated 9:38 aspect of your insulin pathways, is affected. 9:43 So I've actually shifted pretty much. 9:46 So I still track it, 9:48 but I pretty much use my fasting insulin as like the main marker.
Insulin Resistance Markers and Visceral Fat 9:52 In addition to cortisol, triglycerides, HDL, 9:57 HDL ratios, non DL cholesterol, all of those things 10:00 as well as body composition like visceral fat testing. 10:04 Yeah. 10:04 To really guide how well we're treating insulin resistance. 10:09 Great. 10:10 And I you know for the audience I would love you to also differentiate 10:15 because I still feel here people using the term visceral 10:18 fat wrong and visceral fat is not your belly fat. 10:21 Can you help people to again like it's it's there are two different animals 10:25 your belly fat that soft stuff that you makes your belly jiggle. 10:29 It's not what you want. 10:32 It's not necessarily as bad as you think. 10:35 Visceral fat is a whole different animal. 10:37 Yeah. 10:37 And I think this kind of brings us to the second bucket, really is 10:40 like the second bucket of inflammation. Right. 10:42 So when I talk about visceral fat, you know, 10:45 I think many influencers who are trying to understand as real fat, 10:50 they, they point to their belly, 10:51 but what they really mean is the mesenteric fat, right? 10:54 Because for many people, the visceral fat we talk about, it's like, oh, 10:58 think of your, you know, your grandpa with the pot belly. 11:02 You know, you poke at it and his belly is kind of hard, but he's got a big belly. 11:06 And people say that's visceral fat. 11:08 And that's why I think they associate it with belly fat. 11:11 But you're so right. 11:12 Subcutaneous fat, that jiggly fat that's underneath 11:15 the skin is actually far less dangerous long term than visceral fat. 11:19 Granted, if you have a lot of subcutaneous fat, 11:21 you're definitely going to have a lot of this real fat. 11:23 Visceral fat is the fact that is surrounding your organs. 11:26 It is not as associated with the skin. 11:29 It's in the mesenteric of the bow. 11:31 It's surrounding your liver. 11:32 Those are the two main places that people will get it 11:35 surrounding their hearts, surrounding their kidneys. 11:37 And it's because you have that fat there to push in and provide energy 11:42 to your main organs, and that's how your body keeps those organs safe. 11:48 It says, hey, if we ever go into starvation mode, 11:49 we know we have energy stores. 11:52 The problem is that we've seen from long 11:56 term data is that visceral fat is very highly associated 12:00 with inflammation and with insulin resistance. 12:04 And when you look at your risk of the main killer of Americans, 12:08 which is heart disease, the main causes of heart disease 12:12 are either going to be endovascular damage. 12:15 You get damage to your inside of your blood vessels, which then causes 12:19 the allowance of cholesterol plaques to form where you have insulin resistance, 12:23 where your blood vessels are unable to relax and constrict, 12:28 and also are more prone to inflammation damage 12:31 which increases cholesterol plaques, which then can increase your risk 12:35 of heart disease and stroke. 12:37 So it's really visceral. 12:38 Fat is highly associated with those two buckets inflammation in stone resistance. 12:44 And so obviously body composition testing Dexa bod pod. 12:49 You know, at a minimum a is blanking the one that you hold on 12:53 to the two things. 12:54 Oh yeah. 12:55 The, the the blah blah. 12:58 Yeah. 12:59 It'll come to us, but yeah, it will come true. 13:01 That's hilarious. Yeah. 13:03 I mean my, my Hume scale has like a little. 13:06 Yeah. Has a little handle on it. 13:08 And it's kind of measures the current running through 13:11 your body to assess. 13:14 Yeah. 13:15 Yeah. Yeah. 13:15 So eventually the body. Yeah. Oh my goodness. 13:18 Anybody in body. Jeez. 13:20 So the in body scan at a minimum. 13:22 And I think the in body is not as accurate as those other options. 13:26 But you can use it for trend I think. 13:29 Yeah I mean it may not be absolute information, but it'll give you 13:33 an idea of the direction you're moving it. 13:35 Yeah. Exactly. 13:36 And then when you look at inflammatory markers to track 13:39 when it comes to visceral fat and inflammation, its scope 13:42 which your high sensitive, secretive protein, which is highly 13:46 associated with heart disease and endovascular inflammation, 13:50 elevated ferritin, elevated platelet lymphocyte ratios or neutrophil 13:54 lymphocyte ratios where chronic inflammation can actually 13:58 increase your neutrophils, increase your platelets, 14:00 but doesn't actually increase your lymphocytes. 14:02 And so using some of those replacement markers to trend in addition 14:07 to body composition testing can kind of tell you 14:11 where you're at risk there with visceral fat and long term inflammation. 14:16 Cool. All right. 14:18 So that's two buckets 14:19 insulin resistance and inflammation which as it turns out or related.
Hormonal Shifts, Cortisol, and Growth Hormone 14:22 And I think they're all going to be related. I think we can probably put 14:25 insulin resistance in the middle of the bucket here. 14:27 But let's now move over to like those hormonal imbalances which we know. 14:31 I mean, everybody kind of gets that. 14:33 I think the number four is going to be the one that maybe raises a few eyebrows. 14:37 But yeah, the only thing I'll bring up in addition to obviously the estrogen, 14:41 progesterone and testosterone changes that happen in perimenopause. 14:45 And I talk about testosterone in women often. 14:49 Number one, to thank you. 14:50 Yes, yes, to debunk the miss. 14:53 You know, 14:53 there are some miss out there that it's going to magically change everything. 14:56 But also it has been horribly under treated for so long. 14:59 It's like women with low libido are being told they needed to go 15:03 get these super expensive, 15:04 FDA approved options that work on these different modulators 15:07 in the brain when there testosterone is less than optimal, 15:11 and as soon as they start testosterone therapy, 15:13 they're like, oh my energy, slightly better, my libido is better. 15:16 I can actually orgasm. 15:17 Now, in addition to batch estrogen, 15:20 which I think is so important and every paramount apostle woman 15:23 should be on estrogen in my opinion, because it just helps 15:26 keep your tissues healthy even with systemic estrogen therapy. 15:30 So you have menopausal hormone therapy, you have estrogen, progesterone, 15:34 and whether or not you're using testosterone and vaginal estrogen. 15:37 But another huge hormone shift that I think is important to 15:40 address is both cortisol, which would kind of briefly touched on. 15:44 And then growth hormone. 15:46 Growth hormone goes down with age. 15:50 And growth hormone is interesting because it obviously is anabolic. 15:54 It helps with muscle growth and bone health. 15:56 And at high levels can actually increase 16:00 visceral fat and influence insulin resistance. 16:04 But what's so interesting is we have these peptide therapies 16:08 and we'll dive into this more later. 16:09 But like that is FDA approved for HIV lipodystrophy. 16:13 That decreases visceral fat. 16:14 And so the growth we see that growth hormone in smaller amounts 16:19 decreases visceral fat, which obviously decreases 16:22 our insulin resistance and decreases or inflammation. 16:25 They all connect, right? Yeah. 16:27 And what I have seen in my clinical practice, 16:29 which is was more of a theoretical when I first started doing this. 16:33 It was more mechanistically theoretical, where there's the idea that growth hormone 16:38 actually decreases the conversion from the inactive cortisone to cortisol. 16:43 But I've seen that clinically, where I use growth hormone secreting dogs 16:48 to treat high cortisol levels in puzzle women, 16:51 and they go from a fasting cortisol 14 or 20 to eight 16:57 with significantly decreased joint pain, gut inflammation, 17:02 brain fog, despite already being on menopausal hormone therapy. 17:06 So that that cortisol growth hormone balance is also a super 17:09 interesting bucket in that hormone bucket. 17:12 And then the last bucket is cellular inefficiency, where, 17:15 you know, most of the things we've been talking about 17:17 have been pretty macro level, right. 17:19 Working on cellular receptors, working in the endovascular, 17:23 working at the hormone level. 17:24 And then you go into the cell itself and you look at mitochondrial 17:29 inefficiencies where women have low energy joint pain, 17:34 brain fog, fatigue, and you look at how 17:38 inflammatory markers go down when you treat mitochondrial 17:42 inefficiencies, when you treat cellular energy for women. 17:46 And so it's just another one of those buckets where I try to help 17:52 my patients, see, hey, we can address all of these, 17:55 but I don't think we should address them all at once. 17:57 And I kind of use that pathway 18:00 as far as like what is most important to treat first, 18:03 because you can imagine if you have raging insulin resistance and your cells 18:06 at a macro level can't even respond to your major endocrine hormones, 18:11 which insulin does have an effect on even your ability to respond 18:15 to estrogen and progesterone. Testosterone. 18:17 Trying to address 18:18 your mitochondrial inefficiencies is not going to work super well. 18:22 Sure. 18:22 So that's kind of the pathway I take is like we need to address this stepwise, 18:26 but also address the pathways based off of symptoms and lab values. 18:31 Yeah, that's really interesting. 18:33 So you start with insulin resistance. 18:34 Or would you start with addressing insulin resistance with the hormone. 18:37 Because you wouldn't you would think that you'd want to bring start to balance out 18:42 hormones kind of almost simultaneously with addressing the insulin resistance. 18:47 Absolutely. 18:48 And I think when I, when I talk about peptide therapies, 18:51 I do it from the perspective, I guess I'm addressing it from the perspective. 18:55 Either the patient is already on 18:56 menopausal hormone therapy and we've addressed that right. 18:59 Or they're not a good candidate, which I would say 19:03 95% of women are good candidates for menopausal hormone therapy. 19:07 You know, the risk of stroke, the risk of clot, the risk of heart 19:10 disease was horribly overstated for a very long time. 19:14 And we now have great data to show that it is much less, 19:18 especially with transdermal or injectable forms. 19:20 But yeah, when I'm talking about peptide therapies for opposites, 19:24 typically, hey, you've already addressed this aspect. 19:28 Okay. 19:28 So then let's jump in because we let me see. 19:31 We're 20 something minutes in I want to get to. 19:34 And not only I, I'm sure people are like okay, now what about the peptides. 19:38 This is a peptide summit. 19:39 Not get to the point. 19:41 But we needed to lay the foundation. 19:43 And I think what's really you know, and this has been echoed by 19:46 almost everyone that I've interviewed, is that you can't bypass the foundations
Peptide Strategy and Nutrition Foundations 19:51 just to jump to peptides like you just can't, unfortunately. 19:55 And there's we're going to leave 19:57 a lot of information off the table here because we don't have a ton of time. 20:00 But I would love to, you know, now have you kind of 20:05 and you spoke a little bit, 20:06 you mentioned Tessa Ellen, which is it's a really interesting growth hormone 20:10 secreted because I think it's almost the only one that's approved by the FDA. 20:13 Now. It's not approved necessarily for perimenopausal women, but 20:17 it was approved for Aids patients going through certain types of therapy 20:21 to literally target that visceral fat. 20:24 And that's to me, that's its biggest superpower, 20:28 is going after the visceral fat. 20:29 But let's talk about your next 20:31 your kind of order of operations on the peptide scale. 20:34 Yeah, absolutely. 20:35 Well, I think I want to echo what you said is like jumping straight to peptides. 20:39 I talk about this on social media all the time. 20:41 It's just like if you're not sleeping, if you're not exercising resistance 20:45 training, like I talk about resistance 20:47 training and weightlifting for women and how important it is all the time. 20:50 If you're not eating 80 to 90% whole food, you know peptides are going to 20:56 not do nearly as much as you think they're going to do. 21:00 And I think having that expectation is so important. 21:03 When you look at the four buckets, you know, you use symptoms, 21:07 you use lab values, you use where someone is in the transition to identify, 21:12 hey, what is the most likely bucket that is important to address now? 21:16 Right. 21:16 Like if someone doesn't have raging insulin resistance 21:19 but they have brain fog, gut inflammation, those issues, 21:22 if they have low energy and joint pain and things like that. 21:26 Identify where to start is important. 21:28 And I will say I do kind of tier them insulin resistance first. 21:31 So obviously the GOP wants some glue titers up 21:35 tight are going to be the first line therapy. 21:39 And I would say for for most women, especially women who have struggled with 21:42 PMOs or formerly PCOS, you know, 21:47 has been my go to because micro 21:50 doses of trees appetite have been helping these patients 21:54 so much with regular periods, lack of heavy periods, 21:58 the hormonal acne and hirsutism, the hair growth. 22:02 So starting with the GOP 22:03 one for insulin resistance is almost always going to be my recommendation. 22:07 And like I said, I think it will become adjunctive, 22:11 like first line adjunctive therapy to menopausal hormone therapy, 22:14 because almost every woman I work with has those metabolic shifts, 22:19 whether you see it in their triglyceride HDL ratios or you see it in their fasting 22:23 insulin, it's happening and their increased visceral fat 22:27 or their increased subcutaneous belly fat, like those shifts are happening. 22:31 And so whether it's a therapeutic dose or a micro dose, 22:34 depending on your BMI and goals, like I think starting with the GOP, one 22:38 will almost always be a recommendation if you hit that insulin resistance bucket. 22:43 Nice question. 22:45 Before you go to the next thing, how are you coaching your patients on diet? 22:49 Because GLP one's great, but what's the are you finding? 22:54 I mean, does it vary from patient to patient? 22:57 Are you finding that there are some universal guidelines 22:59 that you're able to recommend to your patients? 23:02 Because, you know, I would say that a lot of women almost develop. 23:06 They almost develop an eating disorder around periodicals, 23:09 because you get so flipped out by how fast things are changing 23:13 and how you didn't change, like you just don't know where to turn anymore. 23:17 Yeah, I kind of make the joke with my patients is you're going 23:20 to feel like a gym bro, in the sense of how much you have to focus on protein. 23:24 When you look at the Paramount puzzle shift, you start losing 23:28 muscle, and muscle is the organ of lung. 23:31 Like I will harp on this until the day I die is associated with decreased higher 23:35 skeletal muscle mass, is associated with decrease all cause 23:37 mortality, cardiovascular risk, all those things. 23:39 So with the GOP starting in one, I always recommend like increased protein 23:44 for most women, at least 80 to 90, depending on where you're starting. 23:49 As far as but at least 100 using the 1.6g/kg 23:55 or the one gram per ideal body weight is a good place to start. 23:58 And so, like a universal for most people, is going to be 100g of protein 24:02 a day, which sounds like so much for many people. 24:06 And so 24:07 I pretty much always try to focus on an abundance mindset 24:10 with food, where it's what can I add in rather than what can I cut out. 24:14 So starting with, I can add in lean protein to each meal.
Inflammation, Mitochondria, and Longevity Peptides 24:18 I can add in fiber and high volume, low calorie foods to each meal. 24:22 Because when it really comes down to it, if you're focusing on protein and you're 24:26 focusing on high volume, low calorie, high fiber foods 24:29 that are going to help regulate your gut, help with your insulin sensitivity, 24:33 and help with your bowel movements, you're going to be too full 24:36 to eat anything else. 24:38 Yeah, it's really what it comes down to. 24:40 So those are typically my universal guidelines. 24:42 And obviously everyone is different. 24:43 And you do need to typically customize that. 24:46 But typically my universal guideline there. 24:49 Cool. All right. 24:49 Move on. 24:50 Sorry I, 24:50 I stopped you just there, but we just needed to make a little stop on diet. 24:54 Go ahead. 24:55 Absolutely. 24:55 So, you know, a couple of things I also do for insulin sensitivity is, 24:59 you know, five amino one MQ Mozzie, things like that. 25:01 Almost always in addition to a GOP one, I think Mozzie has gained 25:05 a lot of popularity, and people find it good for energy and strength. 25:10 And, you know, 25:11 because it looks like it it blocks myostatin, which blocks muscle growth. 25:15 So if you block miles stat, 25:16 and you can support muscle growth, but I would say the effects of mozzie 25:20 on weight and insulin sensitivity are purely in addition to a GOP one. 25:25 I think it works best when it's combined. 25:28 I don't think it works that great on its own. 25:30 And just in my clinical experience, then you get into the inflammation 25:33 bucket where it's, hey, where is this information coming from? 25:37 Is it visceral fat, or is it more endovascular and gut? 25:41 Because that's really where it's symptom based. 25:44 As far as should we be addressing this with a growth hormone 25:47 secreted dog like CJC 1295 Marilyn or Maryland or Maryland? 25:52 I was obviously the strongest, but I have found that it tends 25:55 to cause more symptoms in especially women because it's stronger, 26:00 you get more vivid dreams, you get more groggy 26:04 in the morning, increased heart rate and anxiety, and so on. 26:08 Our CJC 1295 tend to be my go to for women because they're more mild. 26:13 Someone is FDA approved for growth hormone deficiency in children, 26:17 but I would say CJC 1295 and is the most predictable result 26:22 and the least side effects for for me and my patients. 26:26 Or are you looking at inflammation from an vascular joint? 26:30 And because joint pain is a huge symptom of cause. 26:35 So things like BPC 157, TB 500, 26:38 which I almost always do together because they have, you know, 26:41 synergistic effect, whether it's increasing 26:44 angiogenesis and cell turnover or the actin mobilization of new cells. 26:48 Right. 26:48 And then there's GCHQ, which I think is people think about for their hair 26:54 and their skin, but it actually activates 4000 genes 26:57 associated with inflammation and longevity. 26:59 And so that's a great option. 27:01 And then there's CFPB, which CFPB I would say 27:04 my biggest clinical mistake in the last year has been overlooking CFPB. 27:07 Because I have this I yeah it is it really is powerful for perimenopause. 27:13 I have patients who are saying just a tight and CFPB combo 27:17 has helped their hot flashes, 27:18 their joint pain, their gut issues during perimenopause. 27:22 So trying to tease those things out and doing what's best for your patient. 27:26 Obviously we talked about cortisol and growth hormone how Tessa 27:30 Maryland or 1295 ephemeral and could be helpful for those things. 27:33 I am a fan of cycling those. 27:35 I don't think that anyone should run those long term. 27:37 And then there's the last bucket, which is cellular inefficiencies. 27:42 And I feel very strongly that if you're looking at longevity 27:47 and, you know, looking at how do I not only live longer 27:49 but live better, addressing your cellular and mitochondrial 27:54 function is so important, but it's so hard to do that 27:56 if all those other buckets are raging, right? 27:58 Right. 28:00 But when you look at what truly causes 28:03 aging in the cell, obviously there's a plethora of things. 28:07 But I do firmly believe that reactive oxidative species 28:11 and the damage that they cause to DNA and proteins, right. 28:15 And so when you have aging, whether that's the signs of aging, 28:20 you know, skin, hair, joints, weight, whatever, it's because you got damage 28:25 to a DNA or you got damage to your proteins or a cellular function 28:30 to where it could not function and replicate properly. 28:33 And so whether that's at a telomerase level 28:36 or whether that's at like the mitochondrial or 28:39 or macro level and reactive oxygen species are a huge part of that. 28:43 They damage DNA and proteins. 28:44 And so glutathione like in my opinion, should be a staple for most people once 28:50 they have addressed some of those other buckets, 28:53 because it is the body's powerful and oxidant, it is anti-inflammatory 28:58 and there is great data about the neurocognitive benefit. 29:02 There is great trials that have looked 29:03 at how it decreases risk of cognitive decline. 29:07 And so that's a great place to start. 29:09 And then you get into all of the other mitochondrial peptides. 29:13 NAD obviously is a molecule, not a peptide, but such an important 29:17 cofactor SS 31, which, you know, I think if you're on social media, 29:22 you see a lot of people saying, oh yeah, you can't do 29:25 any other mitochondrial peptide until you do SS one night. 29:28 I don't feel strongly about that. 29:29 I don't know that everyone has cardio lipid damage as strongly 29:33 as we believe, but I do think those mitochondrial peptides 29:37 like SS 31 mozzie five amino one, the ones that are going to act within 29:41 the mitochondria can be very beneficial once you've got a good foundation. 29:46 But I think so many people get lost, I guess get lost in the source, 29:51 if you will, of social media telling them you need to do this, you need to do this. 29:55 And that's why I became so passionate about educating and giving options 29:59 is so people, 30:00 number one, are wasting their money on something from someone's garage 30:03 that may or may not work, 30:04 but also wasting their money on a protocol that isn't going to do much 30:08 if they haven't addressed their other buckets well, 30:10 and it's not personalized to them. 30:12 You know, I think that I think what people don't wear, we're getting lost 30:17 on social media, is all these people hopping on some bandwagon or another. 30:22 The disaster of this is what helped me, and therefore it will help you 30:27 and this weirdo belief that with peptides, 30:31 nothing could possibly go wrong, right? 30:34 And I think we both know that a lot can go wrong. 30:37 And there's some stuff we don't know that can go wrong. 30:40 And to rob yourself of sitting with a practitioner or a medical doctor 30:45 who's going to look at your labs, your symptoms, your stage, your goals. 30:51 And based on those things, figure out what is your protocol look like. 30:56 And we didn't you know, we won't have time here today, but we won't. 30:58 We didn't even get into clearing toxins or pathogens. 31:02 Or if you have any underlying issues or heavy metal issues, 31:06 like all of the things that can actually get in the way, even of the best 31:10 protocol, you're doing yourself a disservice into your point. 31:14 You're wasting time and money. 31:16 In the best case 31:17 scenario, in a worst case scenario, you could actually be making things worse. 31:21 Like people who just jump on the growth hormone streetcar train 31:25 not knowing where their growth hormone levels are out and maybe too high.
Risks, Personalization, and Where to Find Dr. Taylor 31:29 And then you get I've had people say, well, you know, 31:31 my joints are killing me and I my hands are so swollen and I, 31:35 you know, or I've got like I've got heart palpitations at night or I'm 31:39 and I'm like, dude, do you have underlying blood pressure issues? 31:43 Like, you got to step back. 31:46 Yeah, absolutely. 31:47 I mean, it's just so, so funny to be at the spot where I'm at 31:51 where it's like, 31:52 you know, I went to school for 14 years and have educated myself heavily and, 31:57 you know, part of that school in 14 years, however people feel about medical school 32:02 and how it's done, like you learn how to read scientific literature. 32:06 And being a physician who feels strongly about using peptides to help my patients, 32:12 like you have to learn how to read the scientific literature, 32:14 and you also have to know how to combine physiology, 32:18 pathophysiology and pharmacology, which I hate to tell you, 32:23 just because you work out doesn't mean you know that, right? 32:26 Yeah. Yeah, yeah. 32:27 So that absolutely I'm 100% on board with you there. 32:31 Yeah. 32:31 Well, Patrick, kind of at a time, but I want to thank you 32:35 for showing up on my riverside today. 32:39 Absolutely happy to be here. 32:40 It's a pleasure to meet you. 32:42 Can you please let people know where they can find out more about you 32:45 and working with you? 32:46 Do you only work in person or do you also work? 32:49 Are you able to work virtually with people? 32:51 Yeah, actually live vital. 32:54 I work 100% telehealth in all 50 states, and you can find me 32:58 either at IO or you can find me on social media. 33:01 I have my Instagram and YouTube doctor Pat Taylor or TikTok, Pat Taylor 33:07 MD, which who knows if that'll be the next one day from the next right? 33:10 TikToks unknown. 33:12 I feel the same about Instagram. So you know. 33:14 Yeah, yeah. 33:16 So social media or my website and people can also 33:20 reach out at support at IO on email. 33:23 And I'd be more than happy to to work with them. 33:26 Amazing. Thank you so much. 33:28 It's been great talking to you and I look forward to doing it again. 33:31 Yeah. Thank you again. Thanks.
Comments